Skip to content

Success Rates and Risk Factors for Unsuccessful Ultrasound-Guided Brachial Plexus Blockade

Success Rates and Risk Factors for Unsuccessful Ultrasound-Guided Brachial Plexus Blockade

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037502
Enrollment
1440
Registered
2025-07-22
Start date
2025-06-26
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ultra-sound guided blockade of the brachial pluexus

Interventions

Group 1: Observation group: Pat. that have received a ultrasound-guided blockade of the axillary brachial plexus. Retrospective examination of clinical routine data of all included patients to determi

Sponsors

BG Klinikum Hamburg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: underwent surgery and received an ultrasound-guided ABPB between January 2021 - May 2024 in BG Klinikum Hamburg, planned to be the only means of anaesthesia, performed with 1.5% mepivacaine exclusively and an ASA-Classification of =3. Multiple participations are not permitted.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
failure of the nerve blockade, resulting in an intraoperative conversion to general anesthesia The primary endpoint is the failure of the brachial plexus nerve block. This is considered met if, in addition to the regional anesthesia, the patient requires general anesthesia with placement of an airway intraoperatively. This situation is documented in the anesthesia protocol, which is also analyzed as part of the study.

Secondary

MeasureTime frame
success rate of nerve blockade

Countries

Germany

Contacts

Public ContactMathias Baustert

BG Klinikum Hamburg

m.baustert@bgk-hamburg.de040 7306 40995

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026